ID
45466
Description
Principal Investigator: Matthew Hsieh, MD, National Institutes of Health, NHLBI and NIDDK, Bethesda, MD, USA MeSH: Neutropenia https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000507 Benign ethnic neutropenia (BEN) is a clinical condition more commonly observed in African-Americans. It is characterized by a relative reduction in neutrophil count by about 1000 cells per microliter, leading to a decrease in total leukocyte count by similar decrement. Previous reports of this condition showed that there was neither higher frequency nor increased severity of infections in affected individuals. Bone marrow examinations showed normal white cell maturation; and ex vivo culture of marrow cells showed low normal or slightly reduced number of myeloid colonies. Under physiologic stress, the increases in neutrophil and leukocyte counts of BEN individuals are slightly lower, compared to normal African-Americans or Caucasians. These clinical observations suggest that BEN results from a lower 'set point' for cell number in the marrow. Additionally, case reports of familial BEN, the persistence of BEN over many decades in the US, UK, and Africa, and the recent report of Duffy antigen and chemokine receptor (DARC) being associated with neutropenia, all suggest a strong genetic association to neutropenia/leukopenia. Our initial look into microarray analyses in a pilot trial of subjects showed that there were no significant differences in mRNA signals between BEN and normal subjects. Therefore, we are now proposing a larger study, utilizing Illumina Omni Express chips, to look for genetic associations. We have partnered with the Reasons for Geographic and Racial Differences in Stroke study (REGARDS), where nearly half of the cohort are African-Americans. This will be one of the few GWAS being performed in only African-Americans, and will provide valuable genetic information to link with neutropenia and possibly other conditions/diseases. Genotyping was performed by the Johns Hopkins University Center for Inherited Disease Research (CIDR). Quality control of the genotypic and phenotypic data was performed through a collaboration between CIDR and the Genetics Coordinating Center, Department of Biostatistics at the University of Washington, which is funded by a federal contract supported by 14 NIH Institutes (HHSN268200782096C).
Link
Keywords
Versions (2)
- 14/10/22 14/10/22 - Chiara Middel
- 13/12/22 13/12/22 - Kristina Keller
Copyright Holder
Matthew Hsieh, MD, National Institutes of Health, NHLBI and NIDDK, Bethesda, MD, USA
Uploaded on
13 de diciembre de 2022
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
dbGaP phs000507 Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans
Subject ID, age, gender, if participant consent to private research, State in the US where the participant resides, participant history of stroke, participant history of transient ischemic attack, cholesterol, triglycerides, C-reactive protein, blood cell count, and smoking of participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs Old) from the REGARDS" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, and subject source ID of participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs Old) from the REGARDS" project.
- Subject ID, family ID, mother ID, father ID, and sex of participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs old) from the REGARDS" project.
- Sample ID, subject ID, sample source, sample source ID, and sample use variables obtained from participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs Old) from the REGARDS" project.
- Subject ID, age, gender, if participant consent to private research, State in the US where the participant resides, participant history of stroke, participant history of transient ischemic attack, cholesterol, triglycerides, C-reactive protein, blood cell count, and smoking of participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs Old) from the REGARDS" project.
- Sample ID, analyte type, body site where sample was obtained, and tumor status of sample of participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs Old) from the REGARDS" project.
Similar models
Subject ID, age, gender, if participant consent to private research, State in the US where the participant resides, participant history of stroke, participant history of transient ischemic attack, cholesterol, triglycerides, C-reactive protein, blood cell count, and smoking of participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs Old) from the REGARDS" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, and subject source ID of participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs Old) from the REGARDS" project.
- Subject ID, family ID, mother ID, father ID, and sex of participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs old) from the REGARDS" project.
- Sample ID, subject ID, sample source, sample source ID, and sample use variables obtained from participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs Old) from the REGARDS" project.
- Subject ID, age, gender, if participant consent to private research, State in the US where the participant resides, participant history of stroke, participant history of transient ischemic attack, cholesterol, triglycerides, C-reactive protein, blood cell count, and smoking of participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs Old) from the REGARDS" project.
- Sample ID, analyte type, body site where sample was obtained, and tumor status of sample of participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs Old) from the REGARDS" project.
C0011008 (UMLS CUI [1,2])
C0021822 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
C0021822 (UMLS CUI [1,3])
C0038454 (UMLS CUI [1,2])
C0007787 (UMLS CUI [1,2])
C4520857 (UMLS CUI [1,2])
C0035168 (UMLS CUI [1,3])
C4684638 (UMLS CUI [1,2])
No comments